Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors

Oncogene volume 21, pages 7266–7276 (2002)Cite this article

Abstract

The common fragile site FRA6F, located at 6q21, is an extended region of about 1200 kb, with two hot spots of breakage each spanning about 200 kb. Transcription mapping of the FRA6F region identified 19 known genes, 10 within the FRA6F interval and nine in a proximal or distal position. The nucleotide sequence of FRA6F is rich in repetitive elements (LINE1 and LINE2, Alu, MIR, MER and endogenous retroviral sequences) as well as in matrix attachment regions (MARs), and shows several DNA segments with increased helix flexibility. We found that tight clusters of stem-loop structures were localized exclusively in the two regions with greater frequency of breakage. Chromosomal instability at FRA6F probably depends on a complex interaction of different factors, involving regions of greater DNA flexibility and MARs. We propose an additional mechanism of fragility at FRA6F, based on stem-loop structures which may cause delay or arrest in DNA replication. A senescence gene likely maps within FRA6F, as suggested by detection of deletion and translocation breakpoints involving this fragile site in immortal human-mouse cell hybrids and in SV40-immortalized human fibroblasts containing a human chromosome 6 deleted at q21. Deletion breakpoints within FRA6F are common in several types of human leukemias and solid tumors, suggesting the presence of a tumor suppressor gene in the region. Moreover, a gene associated to hereditary schizophrenia maps within FRA6F. Therefore, FRA6F may represent a landmark for the identification and cloning of genes involved in senescence, leukemia, cancer and schizophrenia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bednarek AK, Laflin KJ, Daniel RL, Liao Qiaoyin, Hawkins KA, Aldaz CM . 2000 Cancer Res. 60: 2140–2145

  • Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM . 2001 Cancer Res. 61: 8068–8073

  • Bell DW, Jhanwar SC, Testa JR . 1997 Cancer Res. 57: 4057–4062

  • Bode J, Kohwi Y, Dickinson L, Joh T, Klehr D, Mielke C, Kohwi-Shigematsu T . 1992 Science 255: 195–197

  • Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R . 1997 Hum. Mol. Genet. 6: 193–203

  • Brukner I, Sanchez R, Suck D, Pongor S . 1995 EMBO J. 14: 1812–1818

  • Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, Markey CJ, Beshah E, Guroff JJ, Maxwell ME . 1997 Genomics 43: 1–8

  • Chen C-H, Shih H-H, Wang-Wuu S, Jen Tai J, Wuu K-D . 1998 Hum. Genet. 103: 702–706

  • Cooney KA, Wetzel JC, Consolino CM, Wojno KJ . 1996 Cancer Res. 56: 4150–4153

  • Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M . 1997 Cell 89: 215–225

  • Egeli U, Ozkan L, Tunca B, Kahraman S, Cecener G, Ergul E, Engin K . 2000 Head Neck J. 22: 591–598

  • Gabrielian A, Pongor S . 1996 FEBS Lett. 393: 65–68

  • Gibbs PEM, McGregor WG, Maher VM, Nisson P, Lawrence CW . 1998 Proc. Natl. Acad. Sci. USA 95: 6876–6880

  • Glover TW, Berger C, Coyle J, Echo B . 1984 Hum. Genet. 67: 136–142

  • Gualandi F, Morelli C, Pavan JV, Rimessi P, Sensi A, Bonfatti A, Gruppioni R, Possati L, Stanbridge EJ, Barbanti-Brodano G . 1994 Genes Chrom. Cancer 10: 77–84

  • Hellman A, Rahat A, Scherer SW, Darvasi A, Tsui L-C, Kerem B . 2000 Mol. Cell. Biol. 20: 4420–4427

  • Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA . 1997 Blood 90: 3714–3719

  • Huang H, Qian C, Jenkins RB, Smith DI . 1998a Genes Chrom. Cancer 21: 152–159

  • Huang H, Qian J, Proffit J, Wilber K, Jenkins R, Smith DI . 1998b Oncogene 16: 2311–2319

  • Huang H, Reed CP, Mordi A, Lomberk G, Wang L, Shridhar V, Hartmann L, Jenkins R, Smith DI . 1999 Genes Chrom. Cancer 24: 48–55

  • Hubbard-Smith K, Patsalis K, Pardinas JR, Jha KK, Henderson AS, Ozer HL . 1992 Mol. Cell. Biol. 12: 2273–2281

  • Huebner K, Garrison PN, Barnes LD, Croce CM . 1998 Annu. Rev. Genet. 32: 7–31

  • Huschtscha LI, Holliday R . 1983 J. Cell Sci. 63: 77–99

  • Inoue H, Ishii H, Alder H, Snyder E, Druck T, Huebner K, Croce CM . 1997 Proc. Natl. Acad. Sci. USA 94: 14584–14589

  • Jackson A, Panayiotidis P, Foroni L . 1998 Genomics 50: 34–43

  • Karayianni E, Magnanini C, Orphanos V, Negrini M, Maniatis GM, Spathas DH, Barbanti-Brodano G, Morelli C . 1999 Cytogenet. Cell Genet. 86: 263–266

  • Kohwi-Shigematsu T, Kohwi Y . 1990 Biochemistry 29: 9551–9560

  • Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI . 2000 Genomics 69: 37–46

  • Le Beau MM, Rassool FV, Neilly ME, Espinosa III R, Glover TW, Smith DI, McKeithan TW . 1998 Hum. Mol. Genet. 7: 755–761

  • Le Beau MM, Rowley JD . 1984 Nature 308: 607–608

  • Luderus MEE, De Graaf A, Mattia E, Den Blaauwen JL, Grande MA, De Jong L, Van Driel R . 1992 Cell 70: 949–959

  • Mangelsdorf M, Ried K, Woolatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Ventner D, Baker E . 2000 Cancer Res. 60: 1683–1689

  • Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ . 1994 Genes Chrom. Cancer 10: 286–288

  • Miele ME, Jewett MD, Goldberg SF, Hyatt DL, Morelli C, Gualandi F, Rimessi P, Hicks DJ, Weissman BE, Barbanti-Brodano G, Welch DR . 2000 Int. J. Cancer 86: 524–528

  • Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM . 1999 Proc. Natl. Acad. Sci. USA 96: 7456–7461

  • Mishmar D, Mandel-Gutfroind Y, Margalit H, Rahat A, Kerem B . 1999 Am. J. Hum. Genet. 64: 908–910

  • Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE . 1998 Proc. Natl. Acad. Sci. USA 95: 8141–8146

  • Morelli C, Cardona F, Boyle JM, Negrini M, Barbanti-Brodano G . 1997a Cytogenet. Cell Genet. 79: 97–100

  • Morelli C, Magnanini C, Mungall AJ, Negrini M, Barbanti-Brodano G . 2000 Gene 252: 217–225

  • Morelli C, Mungall AJ, Negrini M, Barbanti-Brodano G, Croce CM . 1998 Cytogenet. Cell Genet. 83: 18–20

  • Morelli C, Sherratt T, Trabanelli C, Rimessi P, Gualandi F, Greaves MJ, Negrini M, Boyle JM, Barbanti-Brodano G . 1997b Cancer Res. 57: 4153–4157

  • Paige AJW, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ, Watson JEV . 2000 Cancer Res. 60: 1690–1697

  • Pappas GJ, Polymeropoulos MH, Boyle JM, Trent JM . 1995 Genomics 25: 124–129

  • Queimado L, Reis A, Fonseca I, Martins C, Lovett M, Soares J, Parreira L . 1998 Oncogene 16: 83–88

  • Queimado L, Seruca R, Costa-Pereira A, Castedo S . 1995 Genes Chrom. Cancer 14: 28–34

  • Rassool FV, Le Beau MM, Shen ML, Neilly ME, Espinosa III R, Ong ST, Boldog F, Drabkin H, McCarroll R, McKeithan TW . 1996 Genomics 35: 109–117

  • Ray FA, Kraemer PM . 1992 Cancer Genet. Cytogenet. 59: 39–44

  • Ray FA, Peabody DS, Cooper JL, Scott-Cram L, Kraemer PM . 1990 J. Cell. Biochem. 42: 13–31

  • Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D . 2000 Hum. Mol. Genet. 9: 1651–1663

  • Sandhu AK, Hubbard-Smith K, Kaur GP, Jha KK, Ozer HL, Athwal RS . 1994 Proc. Natl. Acad. Sci. USA 91: 5498–5502

  • Sheng ZM, Marchetti A, Buttitta F, Champeme MH, Campani D, Bistocchi M, Lidereau R, Callahan R . 1996 Br. J. Cancer 73: 144–147

  • Shridhar V, Staub J, Huntley B, Cliby W, Jenkins R, Pass HI, Hartmann L, Smith DI . 1999 Oncogene 18: 3913–3918

  • Simonic I, Gericke GS . 1996 Hum. Genet. 97: 524–531

  • Smit A . 1996 Curr. Opin. Genet. Dev. 6: 743–748

  • Smith DI, Huang H, Wang L . 1998 Int. J. Oncol. 12: 187–196

  • Starostik P, Greiner A, Schultz A, Zettl A, Peters K, Rosenwald A, Kolve M, Muller-Hermelink HK . 2000 Blood 95: 1180–1187

  • Sutherland GR, Baker E, Richards RI . 1998 Trends Genet. 14: 501–506

  • Talwalkar VR, Scheiner M, Hedges LK, Butler MG, Schwartz HS . 1998 Cancer Genet. Cytogenet. 104: 111–114

  • Tatarelli C, Linnenbach A, Mimori K, Croce CM . 2000 Genomics 68: 1–12

  • Tunca B, Egeli U, Zorluoglu A, Yilmazlar T, Yerci O, Kizil A . 2000a Cancer Genet. Cytogenet. 119: 139–145

  • Tunca B, Egeli U, Zorluoglu A, Yilmazlar T, Yerci O, Kizil A . 2000b Cancer Lett. 152: 201–209

  • Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y, Emi M . 2000 Jpn. J. Cancer Res. 91: 293–300

  • Wang I, Darling J, Zhang JS, Huang H, Liu W, Smith DI . 1999 Hum. Mol. Genet. 8: 431–437

  • Wang L, Paradee W, Mullins C, Shridhar R, Rosati R, Wilke CM, Glover TW, Smith DI . 1997 Genomics 41: 485–488

  • Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW . 1996 Hum. Mol. Genet. 5: 187–195

  • Yunis JJ, Soreng AL . 1984 Science 226: 1199–1204

Download references

Acknowledgements

We thank all members of the chromosome 6 project group at the Sanger Centre, funded by the Wellcome Trust, for continuous support in sequence determination. We also thank Annalisa Peverati, Augusto Bevilacqua, Pietro Zucchini and Iva Pivanti for excellent technical assistance. C Morelli was supported by a fellowship from Fondazione Italiana per la Ricerca sul Cancro (FIRC). This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) and from MURST ex 60%.

Author information

Authors and Affiliations

  1. Department of Experimental and Diagnostic Medicine, Section of Microbiology and Center for Biotechnology, University of Ferrara, Ferrara, I-44100, Italy

    Cristina Morelli, Efthimia Karayianni, Chiara Magnanini, Massimo Negrini & Giuseppe Barbanti-Brodano

  2. The Sanger Centre, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, Cambridgeshire, UK

    Andrew J Mungall

  3. Division of Experimental Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic Foundation, Rochester, 55905, Minnesota MN, USA

    Erik Thorland & David I Smith

Authors
  1. Cristina Morelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Efthimia Karayianni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiara Magnanini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew J Mungall
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erik Thorland
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Massimo Negrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David I Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giuseppe Barbanti-Brodano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Barbanti-Brodano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morelli, C., Karayianni, E., Magnanini, C. et al. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 21, 7266–7276 (2002). https://doi.org/10.1038/sj.onc.1205573

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205573

Keywords

This article is cited by

Search

Advanced search

Quick links